ZA201001014B - (Cyclopropyl-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament - Google Patents

(Cyclopropyl-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament

Info

Publication number
ZA201001014B
ZA201001014B ZA201001014A ZA201001014A ZA201001014B ZA 201001014 B ZA201001014 B ZA 201001014B ZA 201001014 A ZA201001014 A ZA 201001014A ZA 201001014 A ZA201001014 A ZA 201001014A ZA 201001014 B ZA201001014 B ZA 201001014B
Authority
ZA
South Africa
Prior art keywords
phenyl
oxalamides
cyclopropyl
medicament
production
Prior art date
Application number
ZA201001014A
Other languages
English (en)
Inventor
Elisabeth Defossa
Viktoria Dietrich
Guido Haschke
Johanna Kuhlmann
Thomas Klabunde
Siegfried Stengelin
Andreas Herling
Stefan Bartoschek
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of ZA201001014B publication Critical patent/ZA201001014B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/56—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having carbon atoms of carboxamide groups bound to carbon atoms of carboxyl groups, e.g. oxamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/88—Carboxylic acid amides having nitrogen atoms of carboxamide groups bound to an acyclic carbon atom and to a carbon atom of a six-membered aromatic ring wherein at least one ortho-hydrogen atom has been replaced
ZA201001014A 2007-09-21 2010-02-11 (Cyclopropyl-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament ZA201001014B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07291131 2007-09-21

Publications (1)

Publication Number Publication Date
ZA201001014B true ZA201001014B (en) 2010-10-27

Family

ID=39111440

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA201001014A ZA201001014B (en) 2007-09-21 2010-02-11 (Cyclopropyl-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament

Country Status (20)

Country Link
US (1) US8148375B2 (es)
EP (1) EP2203415B1 (es)
JP (1) JP2011509239A (es)
KR (1) KR20100075444A (es)
CN (1) CN101796018A (es)
AR (1) AR070753A1 (es)
AU (1) AU2008303975B2 (es)
BR (1) BRPI0817198A2 (es)
CA (1) CA2700025A1 (es)
CL (1) CL2008002768A1 (es)
CO (1) CO6260061A2 (es)
IL (1) IL204556A (es)
MA (1) MA31979B1 (es)
MX (1) MX2010002419A (es)
NZ (1) NZ584050A (es)
RU (1) RU2010115747A (es)
TW (1) TW200934751A (es)
UY (1) UY31351A1 (es)
WO (1) WO2009039942A1 (es)
ZA (1) ZA201001014B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011107494A1 (de) 2010-03-03 2011-09-09 Sanofi Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
KR101898610B1 (ko) 2010-08-31 2018-09-14 서울대학교산학협력단 ＰＰＡＲδ 활성물질의 태자 재프로그래밍 용도
JP4944286B1 (ja) * 2010-09-22 2012-05-30 エーザイ・アール・アンド・ディー・マネジメント株式会社 シクロプロパン化合物
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2760862B1 (en) 2011-09-27 2015-10-21 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
IN2015DN03795A (es) 2012-10-24 2015-10-02 Inserm Inst Nat De La Santé Et De La Rech Médicale
EP3076959B1 (en) 2013-12-04 2018-07-04 Merck Sharp & Dohme Corp. Antidiabetic bicyclic compounds
US10059667B2 (en) 2014-02-06 2018-08-28 Merck Sharp & Dohme Corp. Antidiabetic compounds
MX2017004950A (es) 2014-10-23 2018-01-16 Eisai R&D Man Co Ltd Composiciones y metodos para tratar el insomnio.
US10426818B2 (en) 2015-03-24 2019-10-01 Inserm (Institut National De La Sante Et De La Recherche Medicale) Method and pharmaceutical composition for use in the treatment of diabetes
TWI796596B (zh) 2018-02-13 2023-03-21 美商基利科學股份有限公司 Pd‐1/pd‐l1抑制劑
CA3093130C (en) 2018-04-19 2023-10-17 Gilead Sciences, Inc. Pd-1/pd-l1 inhibitors
KR20230159715A (ko) 2018-07-13 2023-11-21 길리애드 사이언시즈, 인코포레이티드 Pd-1/pd-l1 억제제
KR102635333B1 (ko) 2018-10-24 2024-02-15 길리애드 사이언시즈, 인코포레이티드 Pd-1/pd-l1 억제제
CN109574920B (zh) * 2018-12-25 2022-03-04 药大制药有限公司 3-腈基-6环丙基吡啶类ido1抑制剂及其用途
WO2020149129A1 (ja) * 2019-01-15 2020-07-23 株式会社カネカ 非対称化合物の製造方法
CN114450011A (zh) * 2019-05-31 2022-05-06 阿沃林特有限公司 用于治疗代谢性疾病的组合物和方法
WO2021071837A1 (en) 2019-10-07 2021-04-15 Kallyope, Inc. Gpr119 agonists
CA3178994A1 (en) 2020-05-19 2021-11-25 Iyassu Sebhat Ampk activators
CN116390925A (zh) 2020-06-26 2023-07-04 卡尔优普公司 Ampk活化剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6890568B2 (en) * 1999-05-24 2005-05-10 Grant Pierce Method for management of blood glucose levels
JP2004531571A (ja) * 2001-05-25 2004-10-14 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド サイトカイン生産のインヒビターとしてのカルバメート及びオキサミド化合物
US20050124667A1 (en) * 2003-10-30 2005-06-09 Eric Sartori Oxamide inhibitors of plasminogen activator inhibitor-1

Also Published As

Publication number Publication date
AU2008303975A1 (en) 2009-04-02
UY31351A1 (es) 2009-04-30
MX2010002419A (es) 2010-03-30
CO6260061A2 (es) 2011-03-22
EP2203415B1 (de) 2016-10-26
JP2011509239A (ja) 2011-03-24
IL204556A0 (en) 2010-11-30
CN101796018A (zh) 2010-08-04
US8148375B2 (en) 2012-04-03
KR20100075444A (ko) 2010-07-02
TW200934751A (en) 2009-08-16
NZ584050A (en) 2011-09-30
WO2009039942A1 (de) 2009-04-02
AU2008303975B2 (en) 2013-05-16
MA31979B1 (fr) 2011-01-03
AR070753A1 (es) 2010-05-05
EP2203415A1 (de) 2010-07-07
US20100261644A1 (en) 2010-10-14
CA2700025A1 (en) 2009-04-02
CL2008002768A1 (es) 2009-03-06
BRPI0817198A2 (pt) 2015-03-17
IL204556A (en) 2013-06-27
RU2010115747A (ru) 2011-10-27

Similar Documents

Publication Publication Date Title
ZA201001015B (en) (Carboxylalkylene-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament
IL204556A0 (en) (cyclopropyl-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament
ZA200908428B (en) Method for the production of a component, and component
ZA200805939B (en) Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
IL219530A (en) Converted 4-aminocyclohexane compounds, drugs containing these compounds and their use in the preparation of drugs
EP2151500A4 (en) BRANCHED A-GLUCAN, THESE PRODUCING A-GLUCOSYLTRANSFERASE, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF
IL195245A0 (en) Substituted prolinamides, production thereof and their use as drugs
EP2130909A4 (en) METHOD OF PRODUCING TOOTH AND TOOTH PRODUCED BY THE METHOD
IL181012A0 (en) Substituted 8-aminoalkoxi-xanthines, method for the production thereof and use thereof as medicaments
HRP20130558T1 (hr) Derivat 17-hidroksi-17-pentafluoretil-estra-4,9(10)-dien-11-arila, postupci za njegovu proizvodnju i njegova uporaba za lijeäśenje bolesti
IL193341A0 (en) Novel azacyclyl-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments
IL193339A0 (en) Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
EP2412706A4 (en) NEW HYDROXAMATE DERIVATIVE, METHOD FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION THEREWITH
EP2025672A4 (en) 7-ELEMENT HETEROCYCLIC RING, PROCESS FOR PRODUCTION THEREOF AND PHARMACEUTICAL USES THEREOF
EP2199446A4 (en) ALUMINUM FIBER MATERIAL, METHOD FOR PRODUCING THE SAME, AND USE
EP2141229A4 (en) PULVERULENT PREPARATION OF LIPASE, PROCESS FOR PRODUCTION THEREOF AND USE THEREOF
PL2346493T3 (pl) Tabletki wielocząstkowe i sposób ich wytwarzania
ZA201000520B (en) Substituted tetrahydronaphthalenes, process for the preparation thereof and the use thereof as medicaments
EP2123662A4 (en) TREHALOSE COMPOUND, METHOD FOR PRODUCING THE COMPOUND, AND IMMUNOSTIMULATING AGENT COMPRISING THE COMPOUND
HK1149011A1 (en) Triazolopyridazines as par1 inhibitors, production thereof, and use for producing medicaments
EP2330212A4 (en) NEW CERAMIDASTINE COMPOUND AND METHOD FOR THE PRODUCTION AND USE THEREOF
EP2327789A4 (en) NEW COMPOUND SIGNAMYCIN, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF
PL1999112T3 (pl) Podstawione 2-amino-4-fenylo-dihydrochinoliny, sposób ich wytwarzania, ich zastosowanie jako leku i lek je zawierający
PT2190913E (pt) Processo para a produção de formulações aquosas, formulações aquosas e a sua utilização
EP2039681A4 (en) CYCLOALKENE DERIVATIVES, PROCESS FOR PRODUCTION OF DERIVATIVES, AND USE THEREOF